Alcyone Therapeutics Incis A Clinical Stage Biotechnology Company Established In 2012Dedicated To Developing Innovative Treatments For Complex Neurological Disordersthe Company Focuses On Enhancing Dosing And Delivery Methods For These Conditions By Leveraging Engineering And Scientific Advancements Alcyone Specializes In Precision Cnscentral Nervous Systemtherapeutics And Has Developed The Falcon Tm Precision Intra Cerebrospinal Fluidcsfdrug Delivery Platformthis Technology Aims To Optimize Cns Dosing Through A Deep Understanding Of Csf Dynamics And Bioengineeringkey Programs Include A Clinical Stage Gene Therapy For Cln3 Batten Disease And A Mirna Sponge Technology For Treating X Linked Genetic Disorderssuch As Rett Syndromealcyone Collaborates With Nationwide Children S Hospital To Advance Its Therapeutic Pipelineemphasizing Its Commitment To Improving Pediatric Care Through Precision Therapeutics
